100
Participants
Start Date
November 30, 2007
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
Dehydroepiandrosterone, BAY86-5314
Treatment with daily oral intake of two capsules containing 50 mg DHEA each. Treatment duration will be 24 weeks
Placebo
Treatment with daily oral intake of two capsules containing Placebo. Treatment duration will be 24 weeks
Berlin
Berlin
Berlin
Berlin
Berlin
Berlin
Berlin
Berlin
Berlin
Berlin
Hamburg
Lead Sponsor
Bayer
INDUSTRY